We are live on ! Find out more
Capital Research Global Investors

Capital Research Global Investors Portfolio holdings

AUM $645B
1-Year Est. Return 30.41%
 

Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.

This Fund
S&P 500
This Quarter Est. Return
-1.87%
1 Year Est. Return
+30.41%
3 Year Est. Return
+111.06%
5 Year Est. Return
+151.95%
10 Year Est. Return
+612.73%
AUM
$645B
AUM Growth
+$103B
Cap. Flow
+$134B
Cap. Flow %
20.75%
Top 10 Hldgs %
35.32%
Holding
499
New
65
Increased
213
Reduced
159
Closed
40

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$9.76B
2
MSFT icon
Microsoft
MSFT
+$9.53B
3
META icon
Meta Platforms (Facebook)
META
+$8.35B
4
AMZN icon
Amazon
AMZN
+$6.25B
5
CSCO icon
Cisco
CSCO
+$5.01B

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$4.73B
2
HAL icon
Halliburton
HAL
+$1.86B
3
EXE
Expand Energy Corp
EXE
+$1.54B
4
AIG icon
American International
AIG
+$1.45B
5
COF icon
Capital One
COF
+$1.43B

Sector Composition

Rank Sector Weight
1 Technology 29.96%
2 Healthcare 12.5%
3 Consumer Discretionary 11.56%
4 Industrials 9.85%
5 Communication Services 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WCN
301
Waste Connections
WCN
$42.1B
$108M 0.02%
+663,735
New +$111M
BIO icon
302
Bio-Rad Laboratories Class A
BIO
$9.52B
$107M 0.02%
385,579
-108,893
-22% -$31.4M
PAX icon
303
Patria Investments
PAX
$1.81B
$107M 0.02%
8,522,855
-659,233
-7% -$9.27M
FCFS icon
304
FirstCash
FCFS
$9.08B
$105M 0.02%
559,461
+22,500
+4% +$4.07M
ODFL icon
305
Old Dominion Freight Line
ODFL
$43.6B
$105M 0.02%
+537,287
New +$100M
ICFI icon
306
ICF International
ICFI
$1.65B
$105M 0.02%
1,604,524
LAZ icon
307
Lazard
LAZ
$4.28B
$104M 0.02%
2,456,726
MATX icon
308
Matsons
MATX
$6.11B
$104M 0.02%
635,093
-26,479
-4% -$4.12M
TLN
309
Talen Energy Corp
TLN
$17B
$103M 0.02%
322,497
-12,880
-4% -$4.55M
SLB icon
310
SLB Ltd
SLB
$79.3B
$103M 0.02%
1,997,896
-8,542,076
-81% -$415M
SKY icon
311
Champion Homes
SKY
$5.15B
$102M 0.02%
1,376,521
-380,942
-22% -$32.8M
ADMA icon
312
ADMA Biologics
ADMA
$2.21B
$101M 0.02%
11,191,116
+4,553,644
+69% +$71.9M
WWD icon
313
Woodward
WWD
$21B
$98.9M 0.02%
276,386
-168,399
-38% -$60.6M
RYTM icon
314
Rhythm Pharmaceuticals
RYTM
$7.9B
$97M 0.02%
1,115,460
+130,374
+13% +$12.7M
XP icon
315
XP
XP
$8.02B
$95.2M 0.01%
+5,001,182
New +$96.6M
FAF icon
316
First American
FAF
$7.39B
$93.2M 0.01%
1,545,825
-1,870,000
-55% -$120M
EMR icon
317
Emerson Electric
EMR
$90.9B
$92.6M 0.01%
707,140
+3,593
+0.5% +$517K
FUTU icon
318
Futu Holdings
FUTU
$14.8B
$90.2M 0.01%
659,318
+623,819
+1,757% +$97M
SSB icon
319
SouthState Bank Corp
SSB
$10.6B
$89.6M 0.01%
968,015
-608,487
-39% -$59.7M
EZPW icon
320
Ezcorp Inc
EZPW
$1.66B
$89.2M 0.01%
3,512,711
+344,963
+11% +$8.27M
NTR icon
321
Nutrien
NTR
$32B
$87.5M 0.01%
1,159,132
+8,083
+0.7% +$576K
FSLR icon
322
First Solar
FSLR
$25.8B
$80.3M 0.01%
406,870
-292,592
-42% -$64.7M
SNY icon
323
Sanofi
SNY
$104B
$80.1M 0.01%
1,661,837
+11,819
+0.7% +$551K
APO.PRA
324
DELISTED
Apollo Global Management Series A
APO.PRA
$79.6M 0.01%
1,361,316
DE icon
325
Deere & Co
DE
$167B
$78.8M 0.01%
139,849
-2,858
-2% -$1.61M

Similar funds

Capital Research Global Investors's Q1 2026 Portfolio in Review

As of Q1 2026, Capital Research Global Investors held 499 positions worth $645B, up 19% from $542B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Capital Research Global Investors deployed $134B of net new capital in Q1 2026, opening 65 new positions and adding to 213 existing holdings. Its largest new stake was Cisco: 63,949,104 shares worth $4.96B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was RTX Corp, an estimated $4.73B trimmed.

  • Capital Research Global Investors's largest Q1 2026 buy was Cisco: 63,949,104 shares worth $4.96B.
  • Capital Research Global Investors added most to Broadcom in Q1 2026, an estimated $9.76B increase.
  • Capital Research Global Investors's biggest Q1 2026 reduction was RTX Corp, cutting an estimated $4.73B.
  • Capital Research Global Investors fully exited Capital One in Q1 2026, selling an estimated $1.43B.
  • Capital Research Global Investors's ten largest holdings make up 35% of its $645B portfolio in Q1 2026.
  • Capital Research Global Investors opened 65 new positions and closed 40 in Q1 2026.
  • Capital Research Global Investors's portfolio value rose 19% quarter-over-quarter to $645B.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.